40

Sepsis is a critical, life-threatening condition and a significant global health burden. It is currently defined as severe organ dysfunction caused by a dysregulatedhost response to infection, with a renewed focus on the immune system's role in its pathophysiology. Despite extensive experimental and clinical research over the past three decades, effective interventions to alter the progression and outcomes of sepsis remain limited. Current evidence-based treatments are primarily confined to fundamental causal and supportive measures, while adjuvant therapies like blood purification and targeted immunotherapy have yet to demonstrate consistent efficacy. This review aims to provide an updated perspective on the immune pathophysiology of sepsis, explore therapeutic strategies targeting various immunological mechanisms, and advocate for a paradigm shift that prioritizes the host response over the pathogen as a potentially more effective therapeutic focus

  • Количество прочтений 40
  • Дата публикации 31-12-2024
  • Язык статьиIngliz
  • Страницы41-57
English

Sepsis is a critical, life-threatening condition and a significant global health burden. It is currently defined as severe organ dysfunction caused by a dysregulatedhost response to infection, with a renewed focus on the immune system's role in its pathophysiology. Despite extensive experimental and clinical research over the past three decades, effective interventions to alter the progression and outcomes of sepsis remain limited. Current evidence-based treatments are primarily confined to fundamental causal and supportive measures, while adjuvant therapies like blood purification and targeted immunotherapy have yet to demonstrate consistent efficacy. This review aims to provide an updated perspective on the immune pathophysiology of sepsis, explore therapeutic strategies targeting various immunological mechanisms, and advocate for a paradigm shift that prioritizes the host response over the pathogen as a potentially more effective therapeutic focus

№ Имя автора Должность Наименование организации
1 Khujaeva S.A. ! Alfraganus university
№ Название ссылки
1 1.Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama. (2016) 315:801–10. 10.1001/jama.2016.0287[DOI] [PMC free article] [PubMed] [Google Scholar]2.Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. (2020) 395:200–11. 10.1016/S0140-6736(19)32989-7[DOI] [PMC free article] [PubMed] [Google Scholar]3.Vincent JL, Jones G, David S, Olariu E, Cadwell KK. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care. (2019) 23:196. 10.1186/s13054-019-2478-6[DOI] [PMC free article] [PubMed] [Google Scholar]4.Levy MM, Rhodes A, Phillips GS, Townsend SR, Schorr CA, Beale R, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med. (2015) 43:3–12. 10.1097/CCM.0000000000000723[DOI] [PubMed] [Google Scholar]5.Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. (2017) 39:517–28. 10.1007/s00281-017-0639-8[DOI] [PubMed] [Google Scholar]6.Rubio I, Osuchowski MF, Shankar-Hari M, Skirecki T, Winkler MS, Lachmann G, et al. Current gaps in sepsis immunology: new opportunities for translational research. Lancet Infect Dis. (2019) 19:e422–e36. 10.1016/S1473-3099(19)30567-5[DOI] [PubMed] [Google Scholar]7.Tang BM, Huang SJ, McLean AS. Genome-wide transcription profiling of human sepsis: a systematic review. Crit Care. (2010) 14:R237. 10.1186/cc9392[DOI] [PMC free article] [PubMed] [Google Scholar]8.Tamayo E, Fernandez A, Almansa R, Carrasco E, Heredia M, LajoC, et al. Pro-and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Europ Cytokine Netw. (2011) 22:82–7. 10.1684/ecn.2011.0281[DOI] [PubMed] [Google Scholar]9.Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. (2016) 2:16045. 10.1038/nrdp.2016.45[DOI] [PMC free article] [PubMed] [Google Scholar]10.Andaluz-Ojeda D, Bobillo F, Iglesias V, Almansa R, Rico L, Gandia F, et al. A combined score of pro-and anti-inflammatory interleukins improves mortality prediction in severe sepsis. Cytokine. (2012) 57:332–6. 10.1016/j.cyto.2011.12.002[DOI] [PubMed] [Google Scholar]11.Chaudhry H, Zhou J, Zhong Y, Ali MM, McGuire F, Nagarkatti PS, et al. Role of cytokines as a double-edged sword in sepsis. In vivo. (2013) 27:669–84.[PMC free article] [PubMed] [Google Scholar]12.Bermejo-Martin JF, Andaluz-Ojeda D, Almansa R, Gandia F, Gomez-Herreras JI, Gomez-Sanchez E, et al. Defining immunological dysfunction in sepsis: A requisite tool for precision medicine. J Infect. (2016) 72:525–36. 10.1016/j.jinf.2016.01.010[DOI] [PubMed] [Google Scholar]13.Drifte G, Dunn-Siegrist I, Tissieres P, Pugin J. Innate immune functions of immature neutrophils in patients with sepsis and severe systemic inflammatory response syndrome. Crit Care Med. (2013) 41:820–32. 10.1097/CCM.0b013e318274647d[DOI] [PubMed] [Google Scholar]14.Nierhaus A, Linssen J, Wichmann D, Braune S, Kluge S. Use of a weighted, automated analysis of the differential blood count to differentiate sepsis from non-infectious systemic inflammation: the intensive care infection score (ICIS). Inflamm Allergy Drug Targets. (2012) 11:109–15. 10.2174/187152812800392841[DOI] [PubMed] [Google Scholar]15.Nierhaus A, Klatte S, Linssen J, Eismann NM, Wichmann D, Hedke J, et al. Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis-a prospective, observational study. BMC Immunol. (2013) 14:8. 10.1186/1471-2172-14-8[DOI] [PMC free article] [PubMed] [Google Scholar]16.Daix T, Guerin E, Tavernier E, Mercier E, Gissot V, Herault O, et al. Multicentric standardized flow cytometry routine assessment of patients with sepsis to predict clinical worsening. Chest. (2018) 154:617–27. 10.1016/j.chest.2018.03.058[DOI] [PubMed] [Google Scholar]17.Cox LE, Walstein K, Vollger L, Reuner F, Bick A, Dotsch A, et al. Neutrophil extracellular trap formation and nuclease activity in septic patients. BMC Anesthes. (2020) 20:15. 10.1186/s12871-019-0911-7[DOI] [PMC free article] [PubMed] [Google Scholar]18.Simmons J, Pittet JF. The coagulopathy of acute sepsis. Curr Opin Anaesth. (2015) 28:227–36. 10.1097/ACO.0000000000000163[DOI] [PMC free article] [PubMed] [Google Scholar]19.Kaplan MJ, Radic M. Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol. (2012) 189:2689–95. 10.4049/jimmunol.1201719[DOI] [PMC free article] [PubMed] [Google Scholar]20.Ibrohimovna, M. S. (2019). TECHNIQUES OF IMPROVING SPEAKING IN ESP CLASSES FOR MILITARY. CONDUCT OF MODERN SCIENCE-2019, 139.21.Musayeva, S. I., & Mengliyeva, S. S. (2022). Kursantlarning madaniyatlararo rivojlantirish.22.Lu T, Kobayashi SD, Quinn MT, Deleo FR. A NET Outcome. Front Immunol. (2012) 3:365. 10.3389/fimmu.2012.00365[DOI] [PMC free article] [PubMed] [Google Scholar]
В ожидании